Reactions of the graft versus host (GVH) type, Aust J Exp Biol Med Sci, vol.47, pp.17-54, 1969. ,
Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen, Nature, vol.249, pp.275-281, 1974. ,
Activation rules: the two-signal theories of immune activation, Nat Rev Immunol, vol.2, pp.439-485, 2002. ,
Translating costimulation blockade to the clinic: lessons learned from three pathways, Immunol Rev, vol.229, pp.294-306, 2009. ,
Costimulation blockade with belatacept in renal transplantation, N Engl J Med, vol.353, pp.770-81, 2005. ,
Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity, J Am Soc Nephrol, vol.18, pp.2268-77, 2007. ,
T cell memory, Annu Rev Immunol, vol.20, pp.551-79, 2002. ,
CD28 negative T cells: is their loss our gain?: CD28 negative T cells, Am J Transplant, vol.14, pp.2460-2466, 2014. ,
CD28 ? T cells: their role in the age-associated decline of immune function, Trends Immunol, vol.30, pp.306-318, 2009. ,
CD28 extinction in human T cells: altered functions and the program of T-cell senescence, Immunol Rev, vol.205, pp.158-69, 2005. ,
Lineage relationship of effector and memory T cells, Curr Opin Immunol, vol.25, pp.556-63, 2013. ,
Big bang theory of stem-like T cells confirmed, Blood, vol.124, pp.476-483, 2014. ,
The who's who of T-cell differentiation: human memory T-cell subsets, Eur J Immunol, vol.43, pp.2797-809, 2013. ,
Cell surface signaling molecules in the control of immune responses: a tide model, Immunity, vol.34, pp.466-78, 2011. ,
Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release, J Exp Med, vol.160, pp.1717-1752, 1984. ,
Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction, J Exp Med, vol.169, pp.239-54, 1989. ,
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells, J Immunol, vol.152, pp.2675-85, 1994. ,
Activation of naive, memory and effector T cells, Curr Opin Immunol, vol.6, pp.90123-90129, 1994. ,
Functional responses and costimulator dependence of memory CD4+ T cells, J Immunol, vol.164, pp.265-72, 2000. ,
Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells, J Exp Med, vol.189, pp.1521-1551, 1999. ,
Memory T cells need CD28 costimulation to remember, Semin Immunol, vol.21, pp.69-77, 2009. ,
T cell activation determined by T cell receptor number and tunable thresholds, Science, vol.273, pp.104-110, 1996. ,
Duration of TCR stimulation determines costimulatory requirement of T cells, Immunity, vol.5, pp.41-52, 1996. ,
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory, J Immunol, vol.167, pp.5565-73, 2001. ,
Differential T cell costimulatory requirements in CD28-deficient mice, Science, vol.261, pp.609-621, 1993. ,
Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells, Int Immunol, vol.14, pp.701-712, 2002. ,
The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus, J Immunol, vol.185, pp.1730-1773, 2010. ,
A novel role for CD28 in thymic selection: elimination of CD28/B7 interactions increases positive selection, Eur J Immunol, vol.35, pp.418-445, 2005. ,
B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8-T cells in the thymus, J Immunol, vol.173, pp.2253-61, 2004. ,
Dendritic cells maximize the memory CD8 T cell response to infection, Immunity, vol.22, pp.561-70, 2005. ,
Bone marrow-derived cells expand memory CD8+ T cells in response to viral infections of the lung and skin, Eur J Immunol, vol.36, pp.327-362, 2006. ,
CTLA4Ig: bridging the basic immunology with clinical application, Immunity, vol.24, pp.233-241, 2006. ,
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system, J Immunol, vol.155, pp.4521-4525, 1995. ,
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris, J Clin Invest, vol.103, pp.1243-52, 1999. ,
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N Engl J Med, vol.349, pp.1907-1922, 2003. ,
Role of ICOS versus CD28 in antiviral immunity, Eur J Immunol, vol.32, pp.3376-85, 2002. ,
Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection, J Immunol, vol.168, pp.3777-85, 2002. ,
A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo, J Immunol, vol.172, pp.981-989, 2004. ,
Role of CD28 for the generation and expansion of antigen-specific CD8+ T lymphocytes during infection with listeria monocytogenes, J Immunol, vol.167, pp.5620-5627, 2001. ,
Critical role of CD28 in protective immunity against Salmonella typhimurium, J Immunol, vol.163, pp.6769-76, 1999. ,
CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68, J Virol, vol.80, pp.9159-70, 2006. ,
Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii, J Immunol, vol.163, pp.3344-53, 1999. ,
Control of memory CD4 T cell recall by the CD28/ B7 costimulatory pathway, J Immunol, vol.177, pp.7698-706, 2006. ,
Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response, J Immunol, vol.180, pp.1148-57, 2008. ,
Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus, Cell Immunol, vol.266, pp.130-134, 2011. ,
Costimulation modulation uncouples protection from immunopathology in memory T cell responses to influenza virus, J Immunol, vol.182, pp.6834-6877, 2009. ,
Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL, J Immunol, vol.169, pp.4094-4101, 2002. ,
Memory CD8+ T cells require CD28 costimulation, J Immunol, vol.179, pp.6494-503, 2007. ,
Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity, J Virol, vol.86, pp.1955-70, 2012. ,
CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection, Elife, vol.3, p.3180, 2014. ,
Inducible deletion of CD28 prior to secondary nippostrongylus brasiliensis infection impairs worm expulsion and recall of protective memory CD4+ T cell responses, PLoS Pathog, vol.10, 2014. ,
Quiescence of memory CD8+ T cells is mediated by regulatory T cells through inhibitory receptor CTLA-4, Immunity, vol.42, pp.1116-1145, 2015. ,
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4, Science, vol.332, pp.600-603, 2011. ,
Antibody-mediated organ-allograft rejection, Nat Rev Immunol, vol.5, pp.807-824, 2005. ,
Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in cynomolgus monkeys, Am J Transplant, vol.8, pp.1662-72, 2008. ,
meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions: Banff 2013 meeting report, Am J Transplant, vol.14, pp.272-83, 2013. ,
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule, Science, vol.257, pp.792-797, 1992. ,
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg, Science, vol.257, pp.789-92, 1992. ,
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo, Proc Natl Acad Sci U S A, vol.89, pp.11102-11107, 1992. ,
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates, Proc Natl Acad Sci U S A, vol.94, pp.8789-94, 1997. ,
Induction therapy with monoclonal antibodies specific for cd80 and cd86 delays the onset of acute renal allograft rejection in non-human primates1, Transplantation, vol.72, pp.377-84, 2001. ,
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation, J Immunol, vol.159, pp.5187-91, 1997. ,
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties, Am J Transplant, vol.5, pp.443-53, 2005. ,
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study), Am J Transplant, vol.10, pp.535-581, 2010. ,
No one is naive: the significance of heterologous T-cell immunity, Nat Rev Immunol, vol.2, pp.417-443, 2002. ,
An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease, J Exp Med, vol.179, pp.1155-61, 1994. ,
Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections, J Immunol, vol.170, pp.4077-86, 2003. ,
,
, Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes, Nat Immunol, vol.8, pp.388-97, 2007.
T cell allorecognition via molecular mimicry, Immunity, vol.31, pp.897-908, 2009. ,
DOI : 10.1016/j.immuni.2009.09.025
URL : https://doi.org/10.1016/j.immuni.2009.09.025
Allo-HLA reactivity of virus-specific memory T cells is common, Blood, vol.115, pp.3146-57, 2010. ,
T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection, J Immunol, vol.169, pp.3686-93, 2002. ,
Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice, Am J Transplant, vol.2, pp.501-510, 2002. ,
Heterologous immunity provides a potent barrier to transplantation tolerance, J Clin Invest, vol.111, pp.1887-95, 2003. ,
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates, Sci Transl Med, vol.3, 2011. ,
Heterologous immunity: an overlooked barrier to tolerance, Immunol Rev, vol.196, pp.147-60, 2003. ,
Memory T cells: a hurdle to immunologic tolerance, J Am Soc Nephrol, vol.14, pp.2402-2412, 2003. ,
Allorecognition pathways in transplant rejection and tolerance, Transplantation, vol.96, pp.681-689, 2013. ,
Follicular helper CD4 T cells (T FH), Annu Rev Immunol, vol.29, pp.621-63, 2011. ,
Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells, J Immunol, vol.188, pp.2643-52, 2012. ,
Expansion of effector memory TCR V 4+CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance, J Immunol, vol.180, pp.3190-200, 2008. ,
Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recall, J Immunol, vol.186, pp.2033-2074, 2011. ,
The allo-and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation: belatacept efficacy and T cell maturation, Am J Transplant, vol.14, pp.319-351, 2014. ,
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates, Nat Med, vol.15, pp.746-755, 2009. ,
Candidaelicited murine Th17 cells express high CTLA-4 compared with Th1 cells and are resistant to costimulation blockade, J Immunol, vol.192, pp.2495-504, 2014. ,
High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept: Th17 cells have high CTLA-4 expression, Am J Transplant, vol.14, pp.607-621, 2014. ,
The roles of CD8 central and effector memory T-cell subsets in allograft rejection, Am J Transplant, vol.8, pp.1809-1827, 2008. ,
Fine-tuning CD4+ central memory T cell heterogeneity by strength of stimulation, Eur J Immunol, vol.38, pp.15-24, 2008. ,
Premature aging of circulating T cells in patients with end-stage renal disease, Kidney Int, vol.80, pp.208-225, 2011. ,
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients: ATG and immune senescence in transplanted patients, Am J Transplant, vol.15, pp.1028-1066, 2015. ,
Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands: molecular phenotype of TCMR, Am J Transplant, vol.14, pp.2565-76, 2014. ,
Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR-class II-B7+ regulatory cells, Am J Transplant, vol.5, pp.2339-2387, 2005. ,
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, pp.17-27, 2010. ,
Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent fab? antibody: preclinical efficacy and safety of FR104, Am J Transplant, vol.12, pp.2630-2670, 2012. ,
FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft: FR104 prevents allograft rejection, Am J Transplant, vol.15, pp.88-100, 2015. ,
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety, J Immunol, vol.191, pp.4599-610, 2013. ,
DOI : 10.4049/jimmunol.1300470
URL : http://www.jimmunol.org/content/191/9/4599.full.pdf
Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities, Transplantation, vol.83, pp.304-317, 2007. ,
DOI : 10.1097/01.tp.0000251426.46312.d5
CD28 ligation induces transplantation tolerance by IFN-?-dependent depletion of T cells that recognize alloantigens, J Clin Invest, vol.113, 2004. ,
CD28-specific antibody prevents graft-versus-host disease in mice, J Immunol, vol.164, pp.4564-4572, 2000. ,
CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation, J Immunol, vol.170, pp.3002-3008, 2003. ,
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412, N Engl J Med, vol.355, pp.1018-1046, 2006. ,
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner: selective CD28 blockade requires CTLA-4, Am J Transplant, vol.11, pp.1599-609, 2011. ,
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation, Trends Immunol, vol.32, pp.428-461, 2011. ,
Improved survival with ipilimumab in patients with metastatic melanoma, N Engl J Med, vol.363, pp.711-734, 2010. ,
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma, N Engl J Med, vol.364, pp.2517-2543, 2011. ,
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies, J Exp Med, vol.206, pp.1717-1742, 2009. ,
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma, J Exp Med, vol.210, 2013. ,
Activating Fc receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies, J Exp Med, vol.210, pp.1685-93, 2013. ,
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells, Cancer Immunol Res, vol.1, pp.32-42, 2013. ,
Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade, J Immunol, vol.175, pp.7746-54, 2005. ,
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma, J Transl Med, vol.6, p.22, 2008. ,
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival, Cancer, vol.116, pp.1767-75, 2010. ,
Biomarkers on melanoma patient T cells associated with ipilimumab treatment, J Transl Med, vol.10, pp.146-146, 2012. ,
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans, Clin Cancer Res, vol.17, pp.4101-4110, 2011. ,
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma, J Transl Med, vol.9, p.204, 2011. ,
An immune-active tumor microenvironment favors clinical response to ipilimumab, Cancer Immunol Immunother, vol.61, pp.1019-1050, 2012. ,
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab, Proc Natl Acad Sci U S A, vol.108, pp.16723-16731, 2011. ,
Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients, Sci Transl Med, vol.6, pp.238-70, 2014. ,
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens, Nature, vol.515, pp.577-81, 2014. ,
DOI : 10.1038/nature13988
URL : http://europepmc.org/articles/pmc4279952?pdf=render
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer, Nature, vol.520, pp.373-380, 2015. ,
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28, J Exp Med, vol.188, pp.205-215, 1998. ,
Abatacept for Crohn's disease and ulcerative colitis, Gastroenterology, vol.143, pp.62-69, 2012. ,
Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis, Gut, vol.55, pp.1059-60, 2006. ,
Eomes-expressing CD8+ T cells and Th17 cells mediate costimulatory blockade-resistant allograft rejection in mice, Am J Transplant, issue.3, p.1, 2015. ,
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection: costimulation blockade alters GC response, Am J Transplant, vol.14, pp.59-69, 2014. ,
Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes Cd28and ICOS, Immunity, vol.30, pp.228-269, 2009. ,
The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells, Immunity, vol.41, pp.1026-1065, 2014. ,
Selective blockade of the CD28/B7/ CTLA4 pathway with monovalent anti-CD28 antibodies versus targeting of B7 With CTLA4-Ig, in non-human primate kidney allograft, Am J Transplant, issue.3, p.1, 2015. ,
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response, Diabetes, vol.60, pp.3223-3257, 2011. ,